C100 (C100) Q2 2026 earnings summary

Executive summary

• Q2 2026 marked by strategic transactions, including divestment of a patent and trademark portfolio and acquisition of a new patent portfolio from Hunter Capital AB (publ).

• Focus on streamlining operations, reassessing assets, and positioning for long-term value creation.

• Fusion of two wholly owned subsidiaries initiated to simplify group structure.

Financial highlights

• Net sales for Q2 2026 reached 2.996 MSEK, up from 0 SEK in Q2 2025; six-month net sales totaled 2.996 MSEK (207 TSEK previous year).

• EBITDA for Q2 2026 was 2.473 MSEK (vs. -1.188 MSEK Q2 2025); six-month EBITDA at 2.213 MSEK (1.650 MSEK previous year).

• Net income after financial items for Q2 2026 was 2.442 MSEK (vs. -1.196 MSEK Q2 2025); six-month net income at 2.162 MSEK (1.200 MSEK previous year).

• Earnings per share for Q2 2026 were 0.0075 SEK (vs. -0.0735 SEK Q2 2025).

• Cash and cash equivalents at period end were 4.71 MSEK (140 TSEK previous year).

Outlook and guidance

• Continued focus on developing high-potential assets and evaluating new business opportunities for long-term value.

• Entering H2 2026 with a streamlined portfolio and clearer structure.